Inventor · disambiguated record
Stephen Thomas Davis
Also filed as: DAVIS STEPHEN · DAVIS STEPHEN THOMAS
22 granted patents·3 pending applications·440 citations·filing 1998–2021
96Inventor score
Files withTRANSTECH PHARMA INC6TRANSTECH PHARMA LLC5UNIV ILLINOIS5SMITHKLINE BEECHAM CORP4MJALLI ADNAN M M2
Top patents by PatentIndex Score
25 records- 0197US6369086B1Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 1999·Granted Apr 9, 2002·213 cites·18 claims
- 0295US7105529B2Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effectsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Sep 12, 2006·64 cites·5 claims
- 0394US7820821B2Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitorsTRANSTECH PHARMA INC·Filed 2007·Granted Oct 26, 2010·25 cites·28 claims
- 0491US7906507B2Oxadiazoanthracene compounds for the treatment of diabetesTRANSTECH PHARMA INC·Filed 2010·Granted Mar 15, 2011·12 cites·17 claims
- 0590US7790714B2Oxadiazoanthracene compounds for the treatment of diabetesTRANSTECH PHARMA INC·Filed 2010·Granted Sep 7, 2010·10 cites·28 claims
- 0690US7727983B2Oxadiazoanthracene compounds for the treatment of diabetesTRANSTECH PHARMA INC·Filed 2009·Granted Jun 1, 2010·11 cites·46 claims
- 0787US6541503B2Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Apr 1, 2003·22 cites·17 claims
- 0886US8703766B2Oxadiazoanthracene compounds for the treatment of diabetesTRANSTECH PHARMA LLC·Filed 2013·Granted Apr 22, 2014·6 cites·17 claims
- 0985US8524708B2Oxadiazoanthracene compounds for the treatment of diabetesMJALLI ADNAN M M·Filed 2010·Granted Sep 3, 2013·6 cites·17 claims
- 1082US9120813B2Oxadiazoanthracene compounds for the treatment of diabetesTRANSTECH PHARMA LLC·Filed 2014·Granted Sep 1, 2015·4 cites·17 claims
- 1182US6620818B1Method for reducing the severity of side effects of chemotherapy and/or radiation therapySMITHKLINE BEECHAM CORP·Filed 2000·Granted Sep 16, 2003·15 cites·12 claims
- 1281US11117920B2Amphotericin B derivatives with improved therapeutic indexUNIV ILLINOIS·Filed 2019·Granted Sep 14, 2021·1 cites·13 claims
- 1381US8933222B2Oxadiazoanthracene compounds for the treatment of diabetesTRANSTECH PHARMA LLC·Filed 2014·Granted Jan 13, 2015·3 cites·4 claims
- 1480US10323057B2Amphotericin B derivatives with improved therapeutic indexUNIV ILLINOIS·Filed 2014·Granted Jun 18, 2019·3 cites·9 claims
- 1579US9175003B2Substituted azoanthracene derivatives and intermediates for preparation thereofTRANSTECH PHARMA LLC·Filed 2015·Granted Nov 3, 2015·2 cites·11 claims
- 1678US6387919B1Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitorsGLAXO WELLCOME INC·Filed 1998·Granted May 14, 2002·34 cites·13 claims
- 1777US11970512B2Amphotericin B derivatives with improved therapeutic indexUNIV ILLINOIS·Filed 2021·Granted Apr 30, 2024·0 cites·12 claims
- 1877US11028114B2Amphotericin B derivatives with improved therapeutic indexUNIV ILLINOIS·Filed 2019·Granted Jun 8, 2021·1 cites·12 claims
- 1977US8987295B2Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereofTRANSTECH PHARMA LLC·Filed 2012·Granted Mar 24, 2015·3 cites·22 claims
- 2077US8383644B2Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereofTRANSTECH PHARMA INC·Filed 2010·Granted Feb 26, 2013·3 cites·25 claims
- 2177US8377983B2Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitorsTRANSTECH PHARMA INC·Filed 2010·Granted Feb 19, 2013·2 cites·16 claims
- 2257US2009247536A1Bissulfonamide Compounds As Agonists Of GalR1, Compositions, And Methods Of UseMJALLI ADNAN M M·Filed 2009·Application pending·0 cites
- 2349US7582673B2Bissulfonamide compounds as agonists of GalR1, compositions, and methods of useHIGH POINT PHARMACEUTICALS LLC·Filed 2005·Granted Sep 1, 2009·0 cites·53 claims
- 2436US2018273571A1Concise synthesis of urea derivatives of amphotericin bUNIV ILLINOIS·Filed 2016·Application pending·0 cites
- 2534US2015313908A1Combinations of a GLP1R Agonist and Metformin and Use Thereof for the Treatment of Type 2 Diabetes and Other DisordersVTV THERAPEUTICS LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen Thomas Davis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →